Safety of mRNA-Based Vaccines for SARS CoV-2.

2019-nCoV Vaccine mRNA-1273 BNT162 Vaccine COVID-19 / prevention & control COVID-19 Vaccines / adverse effects Humans SARS-CoV-2 / immunology Vaccines, Synthetic / adverse effects mRNA Vaccines

Journal

Chemical research in toxicology
ISSN: 1520-5010
Titre abrégé: Chem Res Toxicol
Pays: United States
ID NLM: 8807448

Informations de publication

Date de publication:
16 08 2021
Historique:
pubmed: 20 5 2021
medline: 25 8 2021
entrez: 19 5 2021
Statut: ppublish

Résumé

SARS-CoV-2 has infected more than 100 million people, causing 2 million deaths globally. Studies on the development of a vaccine ended up with different formulations. We herein discuss the safety record of the two approved vaccines.

Identifiants

DOI: 10.1021/acs.chemrestox.1c00129 PMID: 34009959
pubmed: 34009959
doi: 10.1021/acs.chemrestox.1c00129
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines, Synthetic 0
2019-nCoV Vaccine mRNA-1273 EPK39PL4R4
BNT162 Vaccine N38TVC63NU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1823-1825

Auteurs

Beatrice Barda (B)

Department of Medicine, Ospedale La Carità, Locarno 6900, Switzerland.
ORCID: 0000-0001-5551-3370

Andreas Cerny (A)

Fondazione Epatocentro Ticino, Lugano 6900, Switzerland.
ORCID: 0000-0003-0068-0168

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Antigènes › Vaccins synthétiques › Vaccins à base d'acide nucléique › Vaccins à ARNm › Vaccin ARNm-1273 contre la COVID-19 › Safety of mRNA-Based Vaccines for SARS CoV-2.
questionsmedicales.fr › Facteurs biologiques › Antigènes › Vaccins synthétiques › Vaccins à base d'acide nucléique › Vaccins à ARNm › Vaccin BNT162 › Safety of mRNA-Based Vaccines for SARS CoV-2.
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Safety of mRNA-Based Vaccines for SARS CoV-2.
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Vaccins contre la COVID-19 › Safety of mRNA-Based Vaccines for SARS CoV-2.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Safety of mRNA-Based Vaccines for SARS CoV-2.
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Safety of mRNA-Based Vaccines for SARS CoV-2.
questionsmedicales.fr › Facteurs biologiques › Antigènes › Vaccins synthétiques › Safety of mRNA-Based Vaccines for SARS CoV-2.
questionsmedicales.fr › Facteurs biologiques › Antigènes › Vaccins synthétiques › Vaccins à base d'acide nucléique › Vaccins à ARNm › Safety of mRNA-Based Vaccines for SARS CoV-2.